Request for Nominations of Candidates To Serve on the Board of Scientific Counselors (BSC), Office of Infectious Diseases (OID), 76416-76417 [2011-31429]
Download as PDF
<![CDATA[
76416
Federal Register / Vol. 76, No. 235 / Wednesday, December 7, 2011 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Type of respondents
Form name
General Public/Healthcare Professionals Focus
groups.
General Public/Healthcare Professionals Interviews ...
Screening form ..................................
Focus Groups ....................................
Screening Form .................................
Interviews ..........................................
3000
1500
2000
1000
1
1
1
1
10/60
1.5
10/60
1
General Public/Healthcare Professionals Large Group
Discussions.
General Public/Healthcare Professionals Surveys ......
Screening Forms ...............................
Large Group Discussion ...................
Screening Forms ...............................
Surveys .............................................
2000
1000
15000
7500
1
1
1
1
10/60
1.5
10/60
45/60
General
tests.
Screening Forms ...............................
Pre/Post Tests ...................................
15000
7500
1
1
10/60
45/60
Public/Healthcare
Professionals
Pre/post
Dated: November 30, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–31407 Filed 12–6–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response (BSC, OPHPR)
srobinson on DSK4SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 1:30 p.m.–4 p.m., January
3, 2012.
Place: This meeting is accessible by Web
Conference. Please contact CDC (see Contact
for More Information) to obtain further
instructions on how to participate by phone
and online.
Status: Open to the public limited only by
web conference. Participation by web
conference is limited by the number of ports
available.
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services (HHS), the Assistant Secretary for
Health (ASH), the Director, Centers for
Disease Control and Prevention (CDC), and
the Director, Office of Public Health
Preparedness and Response (OPHPR),
concerning strategies and goals for the
programs and research within OPHPR,
monitoring the overall strategic direction and
focus of the OPHPR Divisions and Offices,
and administration and oversight of peer
review of OPHPR scientific programs. For
additional information about the Board,
please visit: https://www.cdc.gov/phpr/
science/counselors.htm.
VerDate Mar<15>2010
17:00 Dec 06, 2011
Jkt 226001
Matters To Be Discussed: The agenda items
for this meeting include: a briefing to the
Board on the findings from the mid-project
review of OPHPR’s Preparedness and
Emergency Response Research Centers
followed by a vote on final
recommendations; and an update on OPHPR
strategic plan.
Contact for More Information: Sarah
Henderson, OPHPR, CDC, 1600 Clifton Road,
NE., Mailstop D–44, Atlanta, Georgia 30333;
Telephone: (770) 488–8341; Facsimile: (404)
639–7977; E-mail:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: November 28, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–31109 Filed 12–6–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors (BSC), Office of
Infectious Diseases (OID)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the BSC, OID. This board consists of
17 experts in fields related to infectious
diseases who are selected by the
Secretary of the U.S. Department of
Health and Human Services (HHS). The
board advises the HHS Secretary; the
CDC Director; the OID Director; and the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Directors of the National Center for
Immunization and Respiratory Diseases
(NCIRD), the National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP)
concerning strategies, goals, and
priorities for the programs and research
within the national centers and
monitors the overall strategic direction
and focus of OID and the national
centers.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the board’s
mission. Nominees will be selected by
the HHS Secretary or designee from
authorities knowledgeable in the fields
of infectious diseases and related
disciplines, including epidemiology,
microbiology, bacteriology, virology,
parasitology, mycology, immunology,
public health, entomology, clinical
medicine, and veterinary medicine, as
well as from the general public.
Members may be invited to serve for
terms of up to four years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership shall be
balanced in terms of professional
training and background, points of view
represented, and the committee’s
function. In addition to a broad range of
expertise, consideration is given to a
broad representation of geographic areas
within the U.S., with diverse
representation of both genders, ethnic
and racial minorities, and persons with
disabilities. Nominees must be U.S.
citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
E:\FR\FM\07DEN1.SGM
07DEN1
Federal Register / Vol. 76, No. 235 / Wednesday, December 7, 2011 / Notices
affiliation, mailing address, telephone
number, email address);
• A letter of recommendation stating
the qualifications of the candidate.
Nomination materials must be
postmarked by December 30, 2011, and
sent to: Kim Distel, Office of Infectious
Diseases, Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
telephone (404) 639–2100.
Candidates invited to serve will be
asked to submit the ‘‘Confidential
Financial Disclosure Form for Special
Government Employees Serving on
Federal Advisory Committees at the
Centers for Disease Control and
Prevention.’’ This form allows CDC to
determine whether there is a statutory
conflict between that person’s public
responsibilities as a Special Government
Employee and private interests and
activities, or the appearance of a lack of
impartiality, as defined by Federal
regulation. The form may be viewed and
downloaded at https://www.usoge.gov/
forms/oge450_pdf/oge450_
accessible.pdf. This form should not be
submitted as part of a nomination.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: November 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–31429 Filed 12–6–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Office of Planning, Research and
Evaluation Advisory Committee on
Head Start Research and Evaluation
Administration for Children
and Families (ACF), Department of
Health and Human Services (HHS).
ACTION: Notice.
srobinson on DSK4SPTVN1PROD with NOTICES
AGENCY:
This notice announces a
forthcoming meeting of a public
advisory committee of ACF. The
meeting will be open to the public.
Name of Committee: Advisory
Committee for Head Start Research and
Evaluation.
SUMMARY:
VerDate Mar<15>2010
17:00 Dec 06, 2011
Jkt 226001
General Function of Committee: The
Advisory Committee for Head Start
Research and Evaluation will provide
feedback on the published final report
for the Head Start Impact Study, offering
interpretations of the findings,
discussing implications for practice and
policy, and providing recommendations
on follow-up research, including
additional analysis of the Head Start
Impact Study data. The Committee will
also be asked to provide
recommendations to the Secretary
regarding how to improve Head Start
and other early childhood programs by
enhancing the use of research-informed
practices in early childhood. Finally,
the Committee will be asked to provide
recommendations on the overall Head
Start research agenda, including—but
not limited to—how the Head Start
Impact Study fits within this agenda.
The Committee will provide advice
regarding future research efforts to
inform HHS about how to guide the
development and implementation of
best practices in Head Start and other
early childhood programs around the
country.
DATES: The meeting will be held from
8:30 a.m. to 5 p.m. on January 18–19,
2012.
ADDRESSES: Washington Plaza Hotel, 10
Thomas Circle NW., Washington, DC
20005, Phone: (202) 842–1300.
FOR FURTHER INFORMATION CONTACT:
Jennifer Brooks, Office of Planning,
Research, and Evaluation, email
jennifer.brooks@acfhhs.gov or call (202)
205–8212.
Agenda: The Committee will review
draft recommendations developed by
the subcommittees on the topics of
quality teaching and learning; parent,
family, and community engagement; the
impact of Head Start and Early Head
Start; health and mental health; and
cultural and linguistic responsiveness.
Procedure: Interested persons may
present data, information or views, in
writing, on issues pending before the
Committee. Written submissions may be
made to Jennifer Brooks at
jennifer.brooks@acf.hhs.gov on or before
January 2, 2012. All written materials
provided to the contact person will be
shared with the Committee members.
ACF welcomes the attendance of the
public at this advisory committee
meeting and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Jennifer
Brooks at least seven days in advance of
the meeting. Information about the
Committee and this meeting can be
found at the Committee Web site, http:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
76417
//www.acfhhs.gov/programs/opre/hs/
advisory_com/.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: November 22, 2011.
George H. Sheldon,
Acting Assistant Secretary for Children and
Families.
[FR Doc. 2011–31196 Filed 12–6–11; 8:45 am]
BILLING CODE M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0608]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; MedWatch: The
Food and Drug Administration Medical
Products Reporting Program
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by January 6,
2012.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax:
(202) 395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0291. Also
include the FDA docket number found
in brackets in the heading of this
document.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, (301)
796–3794,
Jonnalynn.Capezzuto@fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\07DEN1.SGM
07DEN1
]]>Agencies
[Federal Register Volume 76, Number 235 (Wednesday, December 7, 2011)]
[Notices]
[Pages 76416-76417]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-31429]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Board of
Scientific Counselors (BSC), Office of Infectious Diseases (OID)
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the BSC, OID. This board
consists of 17 experts in fields related to infectious diseases who are
selected by the Secretary of the U.S. Department of Health and Human
Services (HHS). The board advises the HHS Secretary; the CDC Director;
the OID Director; and the Directors of the National Center for
Immunization and Respiratory Diseases (NCIRD), the National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID), and the National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)
concerning strategies, goals, and priorities for the programs and
research within the national centers and monitors the overall strategic
direction and focus of OID and the national centers.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of the
board's mission. Nominees will be selected by the HHS Secretary or
designee from authorities knowledgeable in the fields of infectious
diseases and related disciplines, including epidemiology, microbiology,
bacteriology, virology, parasitology, mycology, immunology, public
health, entomology, clinical medicine, and veterinary medicine, as well
as from the general public. Members may be invited to serve for terms
of up to four years.
The U.S. Department of Health and Human Services policy stipulates
that committee membership shall be balanced in terms of professional
training and background, points of view represented, and the
committee's function. In addition to a broad range of expertise,
consideration is given to a broad representation of geographic areas
within the U.S., with diverse representation of both genders, ethnic
and racial minorities, and persons with disabilities. Nominees must be
U.S. citizens, and cannot be full-time employees of the U.S.
Government.
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (name,
[[Page 76417]]
affiliation, mailing address, telephone number, email address);
A letter of recommendation stating the qualifications of
the candidate.
Nomination materials must be postmarked by December 30, 2011, and
sent to: Kim Distel, Office of Infectious Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE., Mailstop D10, Atlanta,
Georgia 30333, telephone (404) 639-2100.
Candidates invited to serve will be asked to submit the
``Confidential Financial Disclosure Form for Special Government
Employees Serving on Federal Advisory Committees at the Centers for
Disease Control and Prevention.'' This form allows CDC to determine
whether there is a statutory conflict between that person's public
responsibilities as a Special Government Employee and private interests
and activities, or the appearance of a lack of impartiality, as defined
by Federal regulation. The form may be viewed and downloaded at https://www.usoge.gov/forms/oge450_pdf/oge450_accessible.pdf. This form
should not be submitted as part of a nomination.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and the Agency for
Toxic Substances and Disease Registry.
Dated: November 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-31429 Filed 12-6-11; 8:45 am]
BILLING CODE 4163-18-P
